Carroll Financial Associates’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $72K | Buy |
192
+13
| +7% | +$4.88K | ﹤0.01% | 614 |
|
|
2021
Q3 | $73K | Sell |
179
-220
| -55% | -$89.7K | ﹤0.01% | 627 |
|
|
2021
Q2 | $147K | Buy |
399
+225
| +129% | +$82.9K | 0.01% | 489 |
|
|
2021
Q1 | $50K | Buy |
174
+53
| +44% | +$15.2K | ﹤0.01% | 769 |
|
|
2020
Q4 | $30K | Hold |
121
| – | – | ﹤0.01% | 818 |
|
|
2020
Q3 | $27K | Buy |
121
+114
| +1,629% | +$25.4K | ﹤0.01% | 791 |
|
|
2020
Q2 | $1K | Sell |
7
-1
| -13% | -$143 | ﹤0.01% | 1410 |
|
|
2020
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 1348 |
|
|
2019
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 1426 |
|
|
2019
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 1394 |
|
|
2019
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 1440 |
|
|
2019
Q1 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 1288 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1199 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1182 |
|